Doxycycline post-exposure prophylaxis (doxyPEP): balancing promise and prudence in the prevention of sexually transmitted infections
- PMID: 40613125
- PMCID: PMC12231378
- DOI: 10.2807/1560-7917.ES.2025.30.26.2500454
Doxycycline post-exposure prophylaxis (doxyPEP): balancing promise and prudence in the prevention of sexually transmitted infections
Keywords: doxyPEP; doxycycline; prophylaxis; sexually transmitted infections.
Conflict of interest statement
References
-
- European Centre for Disease Prevention and Control (ECDC). STI cases continue to rise across Europe. Stockholm: ECDC; 10 Feb 2025. Available from: https://www.ecdc.europa.eu/en/news-events/sti-cases-continue-rise-across...
-
- World Health Organization (WHO). Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. Geneva: WHO; 2022. Available from: https://www.who.int/publications/i/item/9789240053779
-
- Molina JM, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018;18(3):308-17. 10.1016/S1473-3099(17)30725-9 - DOI - PubMed
-
- Molina JM, Bercot B, Assoumou L, Rubenstein E, Algarte-Genin M, Pialoux G, et al. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design. Lancet Infect Dis. 2024;24(10):1093-104. 10.1016/S1473-3099(24)00236-6 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources